Authors: Sabina Rinaldi, Martyn Plummer, Carine Biessy, Konstantinos K. Tsilidis, Jane Nautrup Østergaard, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Laure Dossus, Rudolf Kaaks, Annekatrin Lukanova, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Claudia Agnoli, Rosario Tumino, Paolo Vineis, Salvatore Panico, H. Bas Bueno-de-Mesquita, Petra H.M. Peeters, Elisabete Weiderpass, Eiliv Lund, J. Ramón Quirós, Antonio Agudo, Esther Molina, Nerea Larrañaga, Carmen Navarro, Eva Ardanaz, Jonas Manjer, Martin Almquist, Maria Sandström, Joakim Hennings, Kay-Tee Khaw, Julie Kathrine Schmidt, Ruth C. Travis, Graham Byrnes, Augustin Scalbert, Isabelle Romieu, Marc J. Gunter, Elio Riboli, Silvia Franceschi
Venue: JNCI: Journal of the National Cancer Institute
Type: Publication
Abstract: BACKGROUND: Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH) are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological evidence is lacking.METHODS: Three hundred fifty-seven incident TC case patients (n = 300 women and 57 men; mean age at blood collection = 51.5 years) were identified in the EPIC cohort study and matched with 2 (women) or 3 (men) control subjects using incidence density sampling. Matching included study center, sex, age, date, time, and fasting status at blood collect...
(read more)
Topics: 
Internal medicine
Endocrinology
Gastroenterology
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...